EMA and FDA define Real-World Evidence (RWE) as the information derived from the analysis of Real-World Data (RWD) about a medicinal product. RWD includes the data relating to a patient’s health status or the delivery of health care collected from various sources. These sources exclude traditional clinical trials, although FDA considers that hybrid or pragmatic trial designs … [Read more...]